Clinical Trials
37 trialsAdding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
National Cancer Institute (NCI)
Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer
Mayo Clinic
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
M.D. Anderson Cancer Center
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Alliance for Clinical Trials in Oncology
TSC Biosample Repository and Natural History Database
National Tuberous Sclerosis Association
PREDICT
Alliance for Clinical Trials in Oncology
Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease
Case Comprehensive Cancer Center
PANEL
University Hospital, Rouen
Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer
Eastern Cooperative Oncology Group
MATADOR2
Institut Claudius Regaud
The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study
Dana-Farber Cancer Institute
INTERCEPTioN
Mayo Clinic
Cancer Genetic Testing in Ethnic Populations
Mayo Clinic
Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer
Case Comprehensive Cancer Center
PROTECT-C
Queen Mary University of London
STOP-Cancer
ClinLogic LLC
Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer
M.D. Anderson Cancer Center
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
M.D. Anderson Cancer Center
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
M.D. Anderson Cancer Center
Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer
M.D. Anderson Cancer Center
ANDROLIPO
Assistance Publique - Hôpitaux de Paris
GIFTS
Fred Hutchinson Cancer Center
Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)
Mayo Clinic
Identifying and Caring for Individuals With Inherited Cancer Syndrome
OHSU Knight Cancer Institute
ACCELERATE
British Columbia Cancer Agency
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
Mayo Clinic
Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer
City of Hope Medical Center
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
University of California, San Francisco
Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study
Thomas Jefferson University
WISDOM
University of California, San Francisco
ESIGON
Assistance Publique - Hôpitaux de Paris
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
The University of Texas Health Science Center at San Antonio
OPTEC
Ohio State University Comprehensive Cancer Center
GENTleMEN
University of Washington
Family Communications After Genetic Testing
Alliance for Clinical Trials in Oncology
Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial
Academic and Community Cancer Research United
Prostasomes as Diagnostic Tool for Prostate Cancer Detection
Hackensack Meridian Health